000199077 001__ 199077
000199077 005__ 20230212173649.0
000199077 0247_ $$2CORDIS$$aG:(EU-Grant)722619$$d722619
000199077 0247_ $$2CORDIS$$aG:(EU-Call)H2020-MSCA-ITN-2016$$dH2020-MSCA-ITN-2016
000199077 0247_ $$2originalID$$acorda__h2020::722619
000199077 035__ $$aG:(EU-Grant)722619
000199077 150__ $$aBioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease$$y2017-01-01 - 2021-06-30
000199077 371__ $$aFYZIOLOGICKY USTAV AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE (VVI)$$dCzech Republic$$ehttp://www.biomed.cas.cz/fgu/en/index.php$$vCORDIS
000199077 371__ $$aInserm$$bINSERM$$dFrance$$ehttp://english.inserm.fr/$$vCORDIS
000199077 371__ $$aAGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS$$bCSIC$$dSpain$$ehttp://www.csic.es$$vCORDIS
000199077 371__ $$aCENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO$$bCNC$$dPortugal$$ehttp://www.cnbc.pt$$vCORDIS
000199077 371__ $$aINSTYTUT BIOLOGII DOSWIADCZALNEJ IM. M. NENCKIEGO POLSKIEJ AKADEMII NAUK$$bNENCKI$$dPoland$$ehttp://www.nencki.gov.pl$$vCORDIS
000199077 371__ $$aUniversity of Porto$$bUniversity of Porto$$dPortugal$$ehttp://sigarra.up.pt/up/en/WEB_BASE.GERA_PAGINA?p_pagina=home$$vCORDIS
000199077 371__ $$aHelmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)$$bHMGU$$dGermany$$ehttps://www.helmholtz-muenchen.de/en/index.html$$vCORDIS
000199077 371__ $$aUniversity of Bari Aldo Moro$$bUniversity of Bari Aldo Moro$$dItaly$$ehttp://www.uniba.it/english-version$$vCORDIS
000199077 371__ $$aFaculdade de Farmácia da Universidade de Lisboa$$bFFUL$$dPortugal$$ehttp://www.ff.ul.pt$$vCORDIS
000199077 371__ $$aNational Research Council$$bCNR$$dItaly$$ehttp://www.cnr.it/sitocnr/home.html$$vCORDIS
000199077 372__ $$aH2020-MSCA-ITN-2016$$s2017-01-01$$t2021-06-30
000199077 450__ $$aFoie Gras$$wd$$y2017-01-01 - 2021-06-30
000199077 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000199077 680__ $$aFOIE GRAS provides innovative training for 13 early stage researchers (ESRs) to answer two critical and unanswered questions: a) Is hepatic bioenergetic remodelling involved in NAFLD pathogenesis, and target for stratification or therapeutic/lifestyle interventions? and b) Is the disruption of the gut-liver axis involved in NAFLD progression? In Western Societies, there has been a recent surge of non-alcoholic fatty liver disease (NAFLD).  Its progression to nonalcoholic steatohepatitis (NASH) is a leading risk factor for development of Type 2 diabetes, cirrhosis, and hepatocellular carcinoma. FOIE GRAS is first in supporting a cohesive and synergistic intersection of complementary and interdisciplinary training skills from academic and non-academic partners. FOIE GRAS combines strong scientific expertise with integrated and complementary training in translational research, clinical practice, technology commercialization, and public outreach, the combination of which in targeting NAFLD is lacking in the EU. Industrial partners CETICS, Mediagnost and Seahorse Biosciences provide experience on technology commercialization alongside scientific contributions while the affiliated patient organization will contribute with important training in societal awareness topics.  ESRs training will utilize network-wide workshops and secondments to foster translation of basic research to clinical applications and SME creation. This diverse yet integrated skill set enhances the employment prospects of the trained researchers in both academic and non-academic sectors. Researchers will be endowed with excellent basic scientific knowledge and timely technology transfer know-how for developing novel therapeutic approaches for reversing the burden of NAFLD, thereby advancing both health and economic well-being of European citizens and approaching NAFLD research in the EU from its counterparts in the US and Asia.
000199077 909CO $$ooai:juser.fz-juelich.de:823724$$pauthority$$pauthority:GRANT
000199077 909CO $$ooai:juser.fz-juelich.de:823724
000199077 970__ $$aoai:dnet:corda__h2020::d9d4cadf3d5622787c38da7b7220a578
000199077 980__ $$aG
000199077 980__ $$aCORDIS
000199077 980__ $$aAUTHORITY